Corstasis Therapeutics Announces Appointment of Sanjeev Narula to its Strategic Advisory Board

Corstasis Therapeutics has officially announced the addition of Sanjeev Narula to its Strategic Advisory Board. This strategic move is set to bolster the company's efforts in advancing its innovative therapeutic solutions. Narula brings a wealth of experience and expertise to the role, having held significant positions in the pharmaceutical and biotech sectors. His insights are expected to guide Corstasis in navigating the complexities of drug development and market entry. The company expressed enthusiasm about Narula’s appointment, highlighting his track record of success in driving growth and fostering innovation. His contributions are anticipated to play a pivotal role as Corstasis Therapeutics continues to expand its impact in the healthcare landscape.